The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qin, Y.
Right arrow Articles by Hamann, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qin, Y.
Right arrow Articles by Hamann, K. J.
The Journal of Immunology, 2002, 169: 3536-3544.
Copyright © 2002 by The American Association of Immunologists

Fas Resistance of Leukemic Eosinophils Is Due to Activation of NF-{kappa}B by Fas Ligation1

Yimin Qin, Blanca Camoretti-Mercado, Lyubov Blokh, Catherine G. Long, Franklin D. Ko and Kimm J. Hamann2

Section of Pulmonary and Critical Care Medicine, Department of Medicine, University of Chicago, Chicago, IL 60637

TNF family receptors can lead to the activation of NF-{kappa}B and this can be a prosurvival signal in some cells. Although activation of NF-{kappa}B by ligation of Fas (CD95/Apo-1), a member of the TNFR family, has been observed in a few studies, Fas-mediated NF-{kappa}B activation has not previously been shown to protect cells from apoptosis. We examined the Fas-induced NF-{kappa}B activation and its antiapoptotic effects in a leukemic eosinophil cell line, AML14.3D10, an AML14 subline resistant to Fas-mediated apoptosis. EMSA and supershift assays showed that agonist anti-Fas (CH11) induced nuclear translocation of NF-{kappa}B heterodimer p65(RelA)/p50 in these cells in both a time- and dose-dependent fashion. The influence of NF-{kappa}B on the induction of apoptosis was studied using pharmacological proteasome inhibitors and an inhibitor of I{kappa}B{alpha} phosphorylation to block I{kappa}B{alpha} dissociation and degradation. These inhibitors at least partially inhibited NF-{kappa}B activation and augmented CH11-induced cell death. Stable transfection and overexpression of I{kappa}B{alpha} in 3D10 cells inhibited CH11-induced NF-{kappa}B activation and completely abrogated Fas resistance. Increases in caspase-8 and caspase-3 cleavage induced by CH11 and in consequent apoptotic killing were observed in these cells. Furthermore, while Fas-stimulation of resistant control 3D10 cells led to increases in the antiapoptotic proteins cellular inhibitor of apoptosis protein-1 and X-linked inhibitor of apoptosis protein, Fas-induced apoptosis in I{kappa}B{alpha}-overexpressing cells led to the down-modulation of both of these proteins, as well as that of the Bcl-2 family protein, Bcl-xL. These data suggest that the resistance of these leukemic eosinophils to Fas-mediated killing is due to induced NF-{kappa}B activation.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S. Kunigal, S. S. Lakka, P. Joseph, N. Estes, and J. S. Rao
Matrix metalloproteinase-9 Inhibition Down-Regulates Radiation-Induced Nuclear Factor-{kappa}B Activity Leading to Apoptosis in Breast Tumors
Clin. Cancer Res., June 1, 2008; 14(11): 3617 - 3626.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Park, Y.-K. Jung, O.-J. Park, Y. J. Lee, J.-Y. Choi, and Y. Choi
Interaction of Fas Ligand and Fas Expressed on Osteoclast Precursors Increases Osteoclastogenesis
J. Immunol., December 1, 2005; 175(11): 7193 - 7201.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-M. Park, H.-Y. Park, and T. H. Lee
Functional Effects of TNF-{alpha} on a Human Follicular Dendritic Cell Line: Persistent NF-{kappa}B Activation and Sensitization for Fas-Mediated Apoptosis
J. Immunol., October 15, 2003; 171(8): 3955 - 3962.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.